Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramy Mahmoud

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Saudi Journal of Anaesthesia|July 11, 2025
Anesthetic management for Birt-Hogg-Dubé syndrome caseRamy Mahmoud
The New England Journal of Medicine|January 7, 2004
Early Alzheimer's diseaseRamy Mahmoud, Andrew Greenspan
Journal of Minimally Invasive Gynecology|April 27, 2010
Letter to the editorDavid Robinson, Ramy Mahmoud
The New England Journal of Medicine|January 5, 2002
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophreniaJohn G Csernansky, Ramy Mahmoud, Ronald Brenner, et al.
Pharmacoeconomics|July 12, 2002
Methods for claims-based pharmacoeconomic studies in psychosisFrank Gianfrancesco, Ruey-Hua Wang, Ramy Mahmoud, et al.
Pharmacoeconomics|June 8, 2002
Use of healthcare services by patients treated with risperidone versus conventional antipsychotic agentsFrank Gianfrancesco, Michael B Durkin, Ramy Mahmoud, et al.
Clinical Therapeutics|June 18, 2003
Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disordersFrank Gianfrancesco, Amy Grogg, Ramy Mahmoud, et al.
Human Psychopharmacology|June 30, 2007
Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophreniaGahan J Pandina, Carla M Canuso, Eriene Youssef, et al.
The Journal of Nervous and Mental Disease|December 20, 2007
The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectableGeorges Gharabawi, Cynthia Bossie, Ibrahim Turkoz, et al.
Annals of General Psychiatry|February 13, 2009
Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based studyFrank D Gianfrancesco, Gahan Pandina, Ramy Mahmoud, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Saudi Journal of Anaesthesia|July 11, 2025
Anesthetic management for Birt-Hogg-Dubé syndrome caseRamy Mahmoud
The New England Journal of Medicine|January 7, 2004
Early Alzheimer's diseaseRamy Mahmoud, Andrew Greenspan
Journal of Minimally Invasive Gynecology|April 27, 2010
Letter to the editorDavid Robinson, Ramy Mahmoud
The New England Journal of Medicine|January 5, 2002
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophreniaJohn G Csernansky, Ramy Mahmoud, Ronald Brenner, et al.
Pharmacoeconomics|July 12, 2002
Methods for claims-based pharmacoeconomic studies in psychosisFrank Gianfrancesco, Ruey-Hua Wang, Ramy Mahmoud, et al.
Pharmacoeconomics|June 8, 2002
Use of healthcare services by patients treated with risperidone versus conventional antipsychotic agentsFrank Gianfrancesco, Michael B Durkin, Ramy Mahmoud, et al.
Clinical Therapeutics|June 18, 2003
Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disordersFrank Gianfrancesco, Amy Grogg, Ramy Mahmoud, et al.
Human Psychopharmacology|June 30, 2007
Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophreniaGahan J Pandina, Carla M Canuso, Eriene Youssef, et al.
The Journal of Nervous and Mental Disease|December 20, 2007
The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectableGeorges Gharabawi, Cynthia Bossie, Ibrahim Turkoz, et al.
Annals of General Psychiatry|February 13, 2009
Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based studyFrank D Gianfrancesco, Gahan Pandina, Ramy Mahmoud, et al.
Pageof 3